Tumor infiltrating Tregs express higher levels of surface molecules associated with T cell activation, such as 4-1BB, OX40, GITR, LAG-3, TIGIT, CD25, and CTLA-4 (100). This evidence concerns the gene TNFRSF18 and neoplasm.